SCHEMBL4281310

SCHEMBL4281310

CCOC(=O)C1CC(=O)C(C(=O)c2ccc(CC)cc2)=C(O)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPC1 O15118 1/20 0.41
BUB1 O43683 1/20 0.40
HSP90AA1 P07900 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 2/20 0.37
GLA P06280 1/20 0.37
MEN1 O00255 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ESR1 P03372 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
ESR2 Q92731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4284354 0.90 ALDH1A1 (0.46) KDM4EALDH1A1KMT2ALMNAL3MBTL1
SCHEMBL4288123 0.89 LMNA (0.44) KDM4EALDH1A1KMT2ALMNAL3MBTL1
SCHEMBL10337538 0.88 BUB1 (0.49) KDM4EALDH1A1KMT2ABUB1MEN1
SCHEMBL4286872 0.87 LMNA (0.42) KDM4EALDH1A1KMT2ALMNAL3MBTL1
SCHEMBL4281502 0.87 LMNA (0.42) KDM4EALDH1A1KMT2ALMNAL3MBTL1
SCHEMBL4292313 0.86 ALDH1A1 (0.43) KDM4EALDH1A1KMT2ABUB1HSP90AA1
SCHEMBL4289348 0.85 POLB (0.46) KDM4EALDH1A1KMT2ALMNABUB1
SCHEMBL4280973 0.77 ALDH1A1 (0.43) KDM4EALDH1A1KMT2ALMNAL3MBTL1
SCHEMBL24413554 0.76 ALDH1A1 (0.49) KDM4EALDH1A1KMT2ABUB1MEN1
SCHEMBL10001994 0.75 ALDH1A1 (0.48) KDM4EALDH1A1KMT2ABUB1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 KDM4E 1987/4885ALDH1A1 896/4885KMT2A 1397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.